JANELL LUNDGREN: Open Payments
NPI 1447285424 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 29 payments from 7 companies in 2025. Trend: 2023 $414 · 2024 $648 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $161 |
| Teva Pharmaceuticals USA, Inc. | 6 | $148 |
| Janssen Pharmaceuticals, Inc | 6 | $125 |
| Lundbeck LLC | 2 | $33 |
| Alkermes, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: INVEGA SUSTENNA, ABILIFY ASIMTUFII, UZEDY, AUSTEDO XR, REXULTI, ARISTADA, INGREZZA, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
